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Hypotensive neonates who have been treated with dopamine have poorer neurodevelop-
mental outcome than those who have not been treated with dopamine. We speculate that
dopamine stimulates adrenoceptors on cerebral arteries causing cerebral vasoconstriction.
This vasoconstriction might lead to a rightward shift of the cerebral autoregulatory curve;
consequently, infants treated with dopamine would have a higher risk of low cerebral blood
flow at a blood pressure that is otherwise considered “safe”.
Methods
In anaesthetized piglets, perfusion of the brain, monitored with laser-doppler flowmetry, and
cerebral venous saturation was measured at different levels of hypotension. Each piglet
was studied in two phases: a phase with stepwise decreases in MAP and a phase with step-
wise increases in MAP. We randomized the order of the two phases, whether dopamine
was given in the first or second phase, and the infusion rate of dopamine (10, 25, or 40 μg/
kg/min). In/deflation of a balloon catheter, placed in vena cava, induced different levels of
hypotension. At each level of hypotension, fluctuations in MAP were induced by in/deflations
of a balloon catheter in descending aorta.
Results
During measurements, PaCO2 and arterial saturation were stable. MAP levels ranged
between 14 and 82 mmHg. Cerebral autoregulation (CA) capacity was calculated as the
ratio between %-change in cerebrovascular resistance and %-change in MAP induced by
the in/deflation of the arterial balloon. A breakpoint in CA capacity was identified at a MAP of
38±18 mmHg without dopamine and at 44±18, 31±14, and 24±14 mmHg with dopamine
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infusion rates of 10, 25, and 40 μg/kg/min (p = 0.057). Neither the index of steady-state cere-
bral perfusion nor cerebral venous saturation were affected by dopamine infusion.
Conclusion
Dopamine infusion tended to improve CA capacity at low blood pressures while an index of
steady-state cerebral blood flow and cerebral venous saturation were unaffected by dopa-
mine infusion. Thus, dopamine does not appear to impair CA in newborn piglets.
Introduction
Hypotension in newborn infants is associated with higher incidence of mortality and cerebral
injury[1–5]. Cerebral injuries caused by hypotension are heterogeneous with both peri- and
intraventricular haemorrhage as well as ischemic cerebral lesions[1–3,5]; predominantly the
white matter being the most vulnerable area to hypotensive periods[6]. These cerebral injuries
result in poorer long-term neurodevelopmental outcome[4,7]. Maintaining adequate perfu-
sion of vital organs, especially the brain, is the rationale of treating hypotension in newborn
infants. Dopamine raises mean arterial blood pressure (MAP) effectively[8,9] and is the most
commonly used vasopressor in newborn infants[10]. It stimulates both dopaminergic and
adrenergic receptors on the arterial smooth muscle cells, and has a concentration-dependent
biphasic response: vasodilation at low concentrations, caused by stimulation of dopaminergic
receptor, and vasoconstriction at higher concentrations due to adrenergic stimulation[11].
Hypotensive neonates treated with dopamine have poorer long-term neurodevelopmental
outcome than those who have not received dopamine[1,12–14]. These observations are, how-
ever, associations and a causal relation between dopamine therapy and poorer neurodevelop-
mental outcome has not been established. Dopamine is not associated with greater incidence
of adverse neurological outcome than other vasopressors[15].
Cerebral autoregulation (CA) is a protective mechanism that maintains a fairly stable cere-
bral blood flow despite fluctuations in MAP. Cerebral arteries reach their maximal compensa-
tory vasodilation when MAP is at the lower limit of CA. Reduction in MAP below the lower
limit of CA will reduce cerebral blood flow and ultimately expose the brain to ischaemia. We
have previously described an association between impaired CA and dopamine infusion in very
preterm infants[16], unfortunately, the study design did not allow us to determine if this rela-
tion was causal.
The observed association between poor neurodevelopmental outcome and dopamine ther-
apy in hypotensive infants might be explained in different ways: dopamine usage might rather
be an indicator of disease and vulnerability, or maybe dopamine has a direct deleterious effect
on the developing brain as dopamine has been shown to cross the blood-brain-barrier in pre-
term infants[17]. Another concern could be if dopamine affects CA. In support of this last
explanation, increased sympathetic tone induces a rightward shift of the CA curve in adult
humans[18]. Due to its sympathomimetic effects, we speculate that dopamine therapy leads to
a rightward shift of the CA curve. An increased cerebrovascular resistance, due to stimulation
of adrenoceptors, might cause this effect. If dopamine therapy results in a rightward shift of
the CA curve, infants treated with dopamine would have a higher risk of cerebral ischaemia at
a MAP that is otherwise considered “safe” if the infants were not treated with dopamine. The
aim of this study was to test this in a piglet model.
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Materials and methods
The Danish Animal Experiments Inspectorate approved the experimental protocol: 2014-15-
0201-00123.
The sample size calculation was based on a previous study where dopamine infusion
increased cerebral perfusion in piglets (gain-laser doppler flowmetry 3±1.4%/mmHg)[19]. If
we assume to find the same standard deviation, we will need five piglets in each group to detect
a difference in gain-laser doppler flowmetry of 3%/mmHg with 90% power and a two-sided
significance level of 0.05. Therefore, we included six piglets in each dopamine infusion rate
group.
Anaesthesia and monitoring
Anaesthesia was induced by 3% isoflurane and supplemented by 5 mg/kg propofol and 20 μg/
kg fentanyl and maintained on propofol 15–20 mg/kg/h and fentanyl 7 μg/kg/h. Fentanyl was
discontinued after the preparation of the piglet and at least one hour before start of the proto-
col. A bolus of propofol or fentanyl was given if the piglet showed signs of superficial anaesthe-
sia or pain. After tracheostomy, the piglet was connected to a pressure-controlled mechanical
ventilator. Settings were adjusted to maintain PaCO2 between 4–6 kPa and arterial saturation
above 95%. Arterial saturation and heart rate were monitored by pulse oximetry from the fore-
paw (Radical 7, Massimo, Hannover, Germany). Piglets were kept on a heating pad to main-
tain rectal temperature 38.5–39.5˚C.
Surgical preparation
The femoral arteries were cannulated with (i) an arterial line for MAP monitoring and blood
gas sampling (placed in the thoracic part of aorta), and (ii) a 4 FR embolectomy-catheter with
a balloon near its tip (LeMaitre Vascular, Germany) with the purpose of increasing MAP in
the upper part of the body by inflating of the balloon. The arterial balloon catheter was posi-
tioned by inflating the balloon: first inflation of the balloon above the arterial line, resulting in
a flat arterial blood pressure waveform. Then the arterial balloon catheter was drawn back
until inflation of the balloon resulted in increased MAP along with an intact blood pressure
waveform and left there. The femoral veins were cannulated with (i) a 4 FR double lumen cen-
tral venous line for infusion of glucose and dopamine, and (ii) another 4 FR embolectomy-
catheter with the balloon in the inferior vena cava just before the inlet into right atrium
(16cm) with the purpose of decreasing cardiac preload when inflated and hereby to induce
arterial hypotension. Control of the placement was done by checking that MAP was easily
manipulated. In some cases, position was confirmed by x-ray.
Cerebral monitoring
We monitored micro-vascular perfusion by laser-doppler flowmetry (LDF) (PeriFlux 5000,
Stockholm, Sweden). For placement of the LDF probe in the right parietal region, a biopsy
punch was used to perform a craniotomy and dura was leaved intact. The LDF probe was fix-
ated in a specially designed metal washer glued to the skull of the piglet. In this way, we secured
that measurements were from the same point on the cerebral cortex. LDF, measured as perfu-
sion units (PU), are non-absolute values that depend on the number of moving red blood cells
as well as the velocity of these cells. Therefore, relative changes in PU were used as an index of
steady-state cerebral blood flow. Superior sagittal sinus was cannulised and cerebral venous
blood was sampled in order to determine cerebral venous saturation. All piglets recovered for
one hour after preparation.
Dopamine Therapy and Cerebral Autoregulation in Newborn Piglets
PLOS ONE | DOI:10.1371/journal.pone.0170738 January 31, 2017 3 / 13
Randomization and protocol
The experimental protocol is illustrated in Fig 1. The protocol had two phases: a phase where
MAP was decreased and a phase where MAP was increased. Hypotension was induced by
inflating the balloon catheter in vena cava. We intended to decrease/increase MAP in steps of
approximately 10 mmHg. We randomized the order of the two phases and whether dopamine
was given during the first or second phase. Also, each piglet was randomized to receive dopa-
mine at an infusion rate of either 10 μg/kg/min (n = 6), 25 μg/kg/min (n = 6) or 40 μg/kg/min
(n = 6). These dosages were chosen based on previous findings in piglets where 15–25 μg/kg/
min dopamine was required to induce a significant rise in MAP[19–21]. Therefore, the dos-
ages represent (i) a low-dosage, that in theory would only affect the dopaminergic receptors,
(ii) a blood pressure active dosage, and (iii) a supra-standard dosage.
At each level of hypotension, blood samples were drawn from the arterial line and from
superior sagittal sinus. Then, to test the autoregulatory capacity, five fluctuations in MAP were
induced by in- and deflating 0.4 ml saline into the aortic balloon catheter, causing rapid in-
and decreases in the blood pressure, each cycle lasting 60 sec. Between the two phases (i.e
MAP being either in- or decreased), the venous balloon was fully deflated while the piglet
recovered. If dopamine was given during the first phase dopamine infusion rate was reduced
by 10 μg/kg/min every 10 mins during the recovery phase. After dopamine infusion was
stopped the piglet recovered for 30 mins. If dopamine was given in the second phase the piglet
recovered for 30 mins after dopamine infusion was initiated. At the end of the protocol, piglets
were euthanized by pentobarbitone (100 mg/kg) while they were still anaesthetized.
Calculation of cerebral autoregulation capacity
CA capacity was estimated, as described by Tiecks et al[22], as a mean over five MAP fluctua-
tions induced by in- and deflations of the arterial balloon. The calculations were based on the
last 15 sec before in- and deflation of the arterial balloon; in this way, static CA was deter-
mined. Firstly, we calculated estimated cerebrovascular resistance (CVRe) as: CVRe = MAP/
PU. Then CA capacity was calculated as percentage change of CVRe in relation to percentage
change of MAP, i.e. CA capacity = %ΔCVRe / %ΔMAP x 100%, where %ΔCVRe = (CVRe
Fig 1. Experimental protocol. The protocol consisted of two phases: a phase where mean arterial blood pressure (MAP) was decreased
and a phase where MAP was increased. At each MAP level, five small fluctuations in MAP was induced by the balloon catheter placed in
aorta. We randomized the order of the two phases, whether dopamine was given in first or second phase, and the infusion rate of dopamine.
In this illustration the piglet was randomized to have a decreasing MAP in the first phase and an increasing MAP in the second phase, also
dopamine was randomized to be given during the second phase (arrow points to initiation of dopamine). *Indicates inflation of the venous
balloon causing reduced MAP, whereas ** indicates increased MAP caused by deflation of the venous balloon. Before and between the two
phases the piglet recovered for 0.5–1 hour.
doi:10.1371/journal.pone.0170738.g001
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(balloon)—CVRe(baseline)) / CVRe(baseline), and %ΔMAP = MAP(balloon)—MAP(base-
line) / MAP(baseline). Thus, expression of CA capacity is a percentage of full CA capacity, i.e.
perfectly working CA where MAP fluctuations result in no fluctuations in LDF.
Statistics
The relation between MAP and the outcome variables (cerebral venous saturation, an index of
steady-state cerebral blood flow as estimated by LDF, and CA capacity) were best described by
a regression line with a break, i.e. two intersecting regression lines with a breakpoint: a positive
slope below the breakpoint, and a horizontal line above the breakpoint. This method has previ-
ously been used to describe the relationship between MAP and cerebral blood flow[6,23]. We
used non-linear regression to determine the breakpoint, i.e. the MAP where the residual sums
of squares reach a minimum[23].
The following equation was used to describe relationship between one outcome variable
and MAP: ‘Outcome variable’ = (MAP< breakpoint)  ((MAP—breakpoint)  slope) + plateau.
The first bracket in the equation gives a dichotomous outcome– 0 when false and 1 when true.
Thus, if MAP is above the determined breakpoint, the value of the first bracket is zero and the
‘outcome variable’ = plateau. On the other hand, if MAP is below the breakpoint, the value of
the bracket is one and it is possible to calculate the slope of the curve below the breakpoint. We
assumed ‘perfect’ autoregulation above the breakpoint, the ‘plateau’. Since each piglet only
contributed five to seven data points with and without dopamine, respectively, non-linear
regression fitting three parameters (breakpoint, slope, and plateau) will not converge. There-
fore, we determined the common slope and plateau for all the piglets in one analysis. Thereaf-
ter we performed non-linear regression analysis for each piglet to determine individual
breakpoints with the slope and plateau as fixed parameters as determined in the common anal-
ysis. These individual breakpoints were related to dopamine infusion rate by linear regression.
The index of steady-state cerebral blood flow measured by LDF was logarithmic transformed
to obtain variance homogeneity. We used students t-test to compare means in two groups, and
paired t-test when changes in a parameter within the same piglet were tested. Values are given
as mean ± standard deviation or median (range).
Results
Piglets
Eighteen piglets were included in the study (median age 60 hours (range 4–66 hours), weight
1.9 ± 0.2 kg). MAP before start of protocol was 59 ± 10 mmHg. Arterial saturation and arterial
pCO2 were stable during the experiment. None of the piglets needed resuscitation during the
experiment or were euthanized prior to termination of the experiment.
Randomization
None of the outcome variables: Cerebral venous saturation, the index of steady-state cerebral
blood flow, or CA capacity were affected by whether the piglets were randomized to have
dopamine in the first or last phase or whether MAP went high-to-low or low-to-high.
Dopamine and blood pressure
In the low-dosage dopamine group (10μg/kg/min) MAP was unaffected by dopamine infusion
(ΔMAP 4±9 mmHg, p = 0.316), whereas MAP increased when dopamine infusion rates were
25 μg/kg/min (ΔMAP 17±8, p = 0.004) and 40 μg/kg/min (ΔMAP 23±10, p = 0.002).
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Cerebral venous saturation and dopamine
During the induced hypotension, MAP ranged between 14 and 82mmHg. When including all
data in one non-linear regression analysis, we found a slope of 0.78%/mmHg of the cerebral
venous saturation curve below the breakpoint. The plateau was placed at a cerebral venous sat-
uration of 45%. Based on the individual determination of the breakpoints, the mean break-
points were at 47±2 mmHg, 43±6 mmHg, 50±4 mmHg, and 53±6mmHg, without dopamine,
with 10 μg/kg/min, 25 μg/kg/min, and 40 μg/kg/min, respectively. Regression coefficient of the
relation between individual breakpoints of cerebral venous saturation and dopamine infusion
was 0.09 mmHg/μgkg-1min-1 (p = 0.558) and is illustrated in Fig 2a.
Cerebral blood flow and dopamine
The relation between the index of steady-state cerebral blood flow, as indicated by LDF, and
MAP had a positive slope of 1.06%/mmHg below a breakpoint and the plateau was placed at
96% of the baseline LDF value. When the piglets did not receive dopamine the breakpoint was
at 36±18 mmHg. With increasing dopamine infusion rates the breakpoints were at 30±18
mmHg, 35±10 mmHg and 38±18 mmHg. There was no trend between the individual break-
points of an index of steady-state cerebral blood flow and dopamine infusion rate (Fig 2b)
(regression coefficient of -0.02 mmHg/μgkg-1min-1, p = 0.863).
Cerebral autoregulation capacity and dopamine
Like cerebral venous saturation and the index of steady-state cerebral blood flow, CA capacity
had a positive slope below the breakpoint (slope 1.7%/mmHg) and the plateau was placed at a
CA capacity of 26%. The breakpoint was 38±18 mmHg when the piglets did not receive dopa-
mine. Piglets receiving dopamine infusion rates of 10 μg/kg/min, 25 μg/kg/min and 40 μg/kg/
min had breakpoints at 44±18 mmHg, 31±14 mmHg and 24±14 mmHg, respectively (Fig 3).
The relation between individual breakpoints of CA capacity and dopamine infusion had a
regression coefficient of -0.36 mmHg/μgkg-1min-1, p = 0.057 (Fig 2c).
Discussion
Our hypothesis was that dopamine affected CA negatively by inducing cerebral vasoconstric-
tion. We used three different measures to examine our hypothesis. Cerebral venous saturation
is a global estimate of the venous saturation from both hemispheres, whereas the two other
measures: CA capacity, as an estimate of cerebral vasoreactivity, and the index of steady-state
cerebral blood flow are based on perfusion in a very small area of cortex as interrogated by the
laser Doppler light probe. Surprisingly, CA capacity rather tended to improve with increasing
infusion rates of dopamine while there was no suggestion of an effect of dopamine treatment
on the index of steady-state cerebral blood flow or cerebral venous saturation at low levels of
MAP.
Cerebral venous saturation and dopamine
CA maintains cerebral blood flow by cerebral vasodilation when MAP is low. Below the lower
limit of CA, cerebral blood flow falls in proportion with the fall in MAP. As cerebral metabolic
rate of oxygen is the product of cerebral blood flow and cerebral oxygen extraction and if cere-
bral metabolic rate of oxygen is constant, then changes in cerebral oxygen extraction reflect
changes in cerebral blood flow [24]. We chose to use changes in cerebral venous saturation
as a simple indicator of the failure of CA to maintain sufficient cerebral blood flow during
hypotension. Althought oxygen extraction, and consequently cerebral venous saturation, is
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Fig 2. Relation between individual breakpoints of ‘outcome variables’ and dopamine infusion in 18
piglets. Each piglet was studied twice—without and with one of the three infusion rates of dopamine. (a)
Cerebral venous saturation (regression coefficient = 0.09 mmHg/μg*kg-1*min-1, p = 0.558). (b) The index of
steady-state cerebral blood flow (regression coefficient = -0.02 mmHg/μg*kg-1*min-1, p = 0.863). (c) CA
capacity (regression coefficient = -0.36 mmHg/μg*kg-1*min-1, p = 0.057).
doi:10.1371/journal.pone.0170738.g002
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influenced by changes in haemoglobin and haemoglobin did decrease over time (first measure
of haemoglobin 7.5±1.7 vs. last measure of haemoglobin 6.5±1.3), the balanced study design
should have eliminated this effect.
Superior sagittal sinus blood comes from both hemispheres but is dominated by blood
from cortex with higher blood flow. White matter is more vulnerable to ischemia during hypo-
tension [6], thus we may potentially have underestimated white matter ischemia.
The MAP breakpoints, i.e. where the cerebral venous saturation began to drop in response
to a decrease in MAP, were unaffected by dopamine infusion (Fig 2a). This suggests that dopa-
mine did not affect global cerebral blood flow negatively. Tsuji et al, however, showed that oxy-
gen extraction was much less affected at low MAP than was blood flow in newborn piglets[25],
presumably due to a decrease in oxygen consumption. Therefore, it is possible that cerebral
venous saturation was a relatively insensitive indicator of the failure of autoregulation, but
such insensitivity need not interfere with the effect of dopamine.
Fig 3. Relation between mean arterial blood pressure and cerebral autoregulation capacity. This relationship is best
described by a regression line with a breakpoint and are illustrated as the non-linear regression lines in the figure. Below
the breakpoint, the line had a positive slope (1.7%/mmHg); and the line is horizontal above the breakpoint. These
parameters were kept fixed in the individual calculations of breakpoints. Based on individual calculations of breakpoints,
the mean breakpoint without dopamine was at 38mmHg. With 10 μg/kg/min, 25 μg/kg/min and 40 μg/kg/min the mean
breakpoints were at 44mmHg, 31mmHg and 24mmHg, respectively.
doi:10.1371/journal.pone.0170738.g003
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Cerebral blood flow and dopamine
We estimated an index of steady-state cerebral blood flow at each level of hypotension in parie-
tal cortex by LDF. Dopamine infusion did not affect the location of breakpoints (Fig 2b). If
dopamine infusion had a negative effect on CA, we would expect a rightward shift of the
‘MAP-cerebral blood flow’ curve, caused by cerebral vasoconstriction.
Cerebral autoregulation capacity and dopamine
CA capacity quantifies the cerebral arteries’ ability to adjust cerebrovascular resistance in
response to induced fluctuations in MAP, i.e. the vasoreactivity. We were surprised that CA
capacity rather tended to improve at low MAP with higher infusion rates of dopamine (Figs 2c
and 3). A theoretical explanation might be that dopamine infusion induces cerebral vasodila-
tion—and not cerebral vasoconstriction. Dopamine does induce vasodilation at low concen-
trations and vasoconstriction at higher concentrations. In isolated human pial arteries
vasodilation has been observed in the concentration range 5 x 10−8 M to 2 x 10−5 M[26]. If we
assume, that dopamine penetrates the blood-brain-barrier in a passive manner in newborn
piglets, and when extrapolating from the proportion of dopamine that penetrated the blood-
brain-barrier in preterm infants[17], our infusion rates of dopamine would lead to a concen-
tration of dopamine in the cerebrospinal fluid in the order of 10−7–10−6 M. Therefore, dopa-
mine in the infusion rates that we used could, in theory, induce vasodilation. However, these
theoretical considerations are not supported by the two other outcomes in this study. Another
explanation could be that dopamine improved vasoreactivity and therefore reduced the degree
of cerebral vasoparalysis at low MAP. In line with this explanation, dopamine therapy has
been found to prevent loss of CA during hypotension in simulated traumatic brain injury; and
restore the ability of pial arteries to vasodilate in response to hypotension[27]. Also, it has been
shown that infusion of dopamine in high dosages (20–30 μg/kg/min) in 10 days old piglets
restored CA, eventhough the piglets were anaesthetized with isoflurane[28]. We consider it
most prudent to conclude that dopamine treatment does not appear to affect cerebral autore-
gulation negatively in the neonatal piglet.
Strengths and limitations
The advantage of our study is that we compared cerebrovenous oxygenation, an index of
steady-state cerebral blood flow, and CA capacity at comparable levels of MAP with and with-
out dopamine infusion. This is important because an increase in MAP, caused by dopamine
infusion, in itself might affect these variables.
Our study also has limitations. First, we used healthy newborns piglets to mimic hypoten-
sive newborn infants. We do not know if the presence and development of dopaminergic and
adrenergic receptors are identical in piglets and infants. The piglets were healthy, in contrast,
most infants who are treated with dopamine are distressed and might have increased basal
sympathetic tone. Second, we used MAP instead of cerebral perfusion pressure in our descrip-
tion of CA. Minor changes from normal intracranial pressure to lower intracranial pressure
might be expected when we induced hypotension. However, we would not expect intracranial
pressure to vary significantly in our experimental design and Brady et al showed that in gradu-
ally hypotensive newborn piglets an estimate of CA using MAP was highly comparable to an
estimate of CA using cerebral perfusion pressure[29]. Third, an index of steady-state cerebral
blood flow was estimated by LDF. LDF measures perfusion within a very small area of cortex.
It would have been valuable to determine the global cerebral blood flow in absolute terms by
using the colored microsphere technique. However, colored microspheres only allow a limited
number of measurements in each animal and our main interest was to monitor changes in
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cerebral blood flow continuously to estimate CA. This change in CBF cannot be determined
by microsphere technique. It has been shown that LDF correlates well with several gold stan-
dard methods for measuring cerebral blood flow, including the microsphere technique, but
also that relative changes in LDF may underestimate the relative change in CBF by 10–20%
[30,31]. In line with these observations, LDF has been shown to be a reliable method to deter-
mine the lower limit of CA[32,33], which was the purpose of our study. LDF measures were
calculated as changes in PU in each level of hypotension relative to the baseline value. We did
not adjust for the flux at zero perfusion. In our pilot-piglets and the first included piglets
(n = 6) the flux after euthanization was negligible (PU<5) so we decided to ignore it.
When we calculated the breakpoints in the non-linear regression analysis we assumed that
the slope below the breakpoint was the same without and in all three dosages of dopamine. It
is possible, that the slope is affected by dopamine dosage; but the study was not powered to
study this.
Another concern might be if our anaesthetic procedure affects our measurements. Piglets
were initially sedated by isoflurane. It is well described that isoflurane impairs CA[34] and
therefore, isoflurane was stopped as soon as an iv-line was established. Propofol was chosen as
the anaesthetic agent during the experiment because it has been shown to have no effect on
CA[35]. In our protocol, propofol and fentanyl could be supplemented by bolus injections if
the piglet showed signs of superficial anaesthesia or pain. However, bolus injections were only
administered in the preparation phase. Therefore, we find it unlikely that these bolus injections
could influence cerebral blood flow or cerebrovascular resistance during the experimental pro-
tocol and bias our findings.
To ensure equal distribution of design-induced bias, data from each piglet was obtained
with and without dopamine, and with MAP both being lowered and raised. Furthermore, to
exclude a time-dependent bias, the order of dopamine/not dopamine and increasing/decreas-
ing MAP was randomized between piglets. Ideally, each piglet should have been studied
without dopamine and with all three infusion rates of dopamine to eliminate the effect of vari-
ability among piglets. We did not attempt this study design because we expected, based on pre-
vious experience with experiments on newborn piglets, deterioration of the piglet model over
four periods with hypotension and a long experimental time. We considered that measure-
ments during two periods with severe hypotension were a more robust design. Actually, severe
hypotension might induce cerebral ischemia and this could affect autoregulation afterwards.
Despite severe hypotension lasting approximately 10 min, we did not observe any cardiac
arrest. Neither did we see any influence on our measurements (no statistical significant differ-
ences between dopamine-first and dopamine-last data). In this model the short duration of
hypotension and decreased blood flow did not lead to impairment of CA. In an experimental
setting with hypotensive adult cats, ischemic brain lesions were only seen when MAP was low-
ered to 50% of the lower limit of CA for at least 15 min[36].
Conclusion
Dopamine tended to improve cerebral autoregulation capacity at low arterial blood pressure;
however, a beneficial effect of dopamine was not confirmed by improved cerebral blood flow
or cerebrovenous oxygen saturation. We conclude that dopamine therapy does not appear to
affect cerebral autoregulation negatively in hypotensive newborn piglets.
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